LAV Biosciences Fund IV Overview
- Fund Strategy
-
Venture
- Fund Status
-
Fully Invested
- Fund Manager
- LAV (Lilly Asia...
- Size
-
$450M
- Vintage
-
2017
- Dry Powder
-
LAV Biosciences Fund IV General Information
Description
LAV Biosciences Fund IV is a 2017 vintage venture capital fund managed by Lilly Asia Ventures. The fund is located in Hong Kong, Hong Kong and invested in Asia. The fund targeted pharmaceuticals and biotechnology, life sciences and oncology sectors.
Contact Information
Fund Manager's Location
- Room 606-7, Saint George's Building
- 2 Ice House Street, Central
- Hong Kong
- Hong Kong
LAV Biosciences Fund IV Investments (58)
LAV Biosciences Fund IV has made a total of 58 investments. Its most recent deal was a with Nucleix for . The deal was made on 01-Dec-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Nucleix | 01-Dec-2021 | Diagnostic Equipment | Product Development | |||
| Cornerstone Robotics | 01-Nov-2021 | Surgical Devices | Generating Revenue | |||
| Hopstem Biotech | 31-Oct-2021 | Drug Discovery | Generating Revenue | |||
| CinCor Pharma | 22-Sep-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Xellsmart | 09-Sep-2021 | Drug Discovery | Generating Revenue | |||
| AbogenBio | 23-Aug-2021 | Drug Discovery | Generating Revenue | |||
| ADARx Pharmaceuticals | 17-Aug-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Zentera Therapeutics | 02-Aug-2021 | Drug Discovery | Clinical Trials - General | |||
| ProfoundBio | 16-Jun-2021 | Early Stage VC (Series A) | Drug Discovery | Product Development | ||
| Synthekine | 10-Jun-2021 | Early Stage VC (Series B) | Drug Discovery | Pre-Clinical Trials |
LAV Biosciences Fund IV Investment Strategy
LAV Biosciences Fund IV Limited Partners (4)
California State Teachers' Retirement System is one of LAV Biosciences Fund IV’s 4 limited partners. Its latest Original was on 14-Aug-2017.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| California State Teachers' Retirement System | Current | 14-Aug-2017 | Original | ||
| Lilly USA | Current | 14-Aug-2017 | Original | ||
| San Francisco Employees' Retirement System | Current | 14-Aug-2017 | Original | ||
| Los Angeles County Employees' Retirement Association | Public Pension Fund | Current | 28-Feb-2017 | Original |
LAV Biosciences Fund IV Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
LAV Biosciences Fund IV Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
LAV Biosciences Fund IV Benchmark (22)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| CreditEase Fintech Investment Fund | |||||
| LAV Biosciences Fund IV | 31-Mar-2026 | ||||
| Beacon VC Fund | |||||
| IDG China Venture Capital Fund V | 31-Mar-2026 | ||||
| Xiang He Fund I | |||||
| Runda Industrial Development RMB Fund, Suzhou Suma Industrial Park | |||||
| Samsung Automotive Innovation Fund | |||||
| Genesis Capital I | |||||
| Source Code Fund USD III | |||||
| SINO-BLR Industrial Investment Fund |
LAV Biosciences Fund IV FAQs
-
What is LAV Biosciences Fund IV?
LAV Biosciences Fund IV is a 2017 vintage venture capital fund managed by Lilly Asia Ventures.
-
Who manages LAV Biosciences Fund IV?
LAV Biosciences Fund IV is managed by LAV (Lilly Asia Fund).
-
Where is LAV Biosciences Fund IV domiciled?
LAV Biosciences Fund IV is domiciled in Cayman Islands.
-
What is LAV Biosciences Fund IV's size?
LAV Biosciences Fund IV has a size of $450M.
-
What type of fund is LAV Biosciences Fund IV?
The fund type of LAV Biosciences Fund IV is Venture.
-
What is the status of LAV Biosciences Fund IV?
LAV Biosciences Fund IV is fully invested.
-
What has LAV Biosciences Fund IV invested in?
LAV Biosciences Fund IV has made numerous investments in companies like Nucleix, Cornerstone Robotics, and Hopstem Biotech within the Diagnostic Equipment, Surgical Devices, and Drug Discovery industries.
-
What has LAV Biosciences Fund IV invested in recently?
LAV Biosciences Fund IV's latest investment was on 01-Dec-2021 in Nucleix, a company within the Diagnostic Equipment industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process